Literature DB >> 18438177

Testosterone and depression in men.

Revital Amiaz1, Stuart N Seidman.   

Abstract

PURPOSE OF REVIEW: The purpose of the review is to update the current literature regarding the role, if any, that testosterone plays in depressive illness. We have considered the influences on depression of endogenous testosterone, that is, hypogonadism and depression; and exogenous testosterone, that is, as a potential antidepressant. RECENT
FINDINGS: Studies do not support a consistent relationship between testosterone level and mood. There may be vulnerable subpopulations in whom hypogonadism contributes to depression; and chronic depressive illness may lead to hypogonadism in some men. Results from multiple randomized, controlled clinical trials are conflicting. Most do not support testosterone as a broadly effective antidepressant, but it may be effective in carefully selected populations, such as hypogonadal men, antidepressant-resistant men, men with early onset depression, and/or HIV-infected men.
SUMMARY: There is little support for a pervasive influence of testosterone on mood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438177     DOI: 10.1097/MED.0b013e3282fc27eb

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  23 in total

1.  Differentiation of umbilical cord mesenchymal stem cells into steroidogenic cells in comparison to bone marrow mesenchymal stem cells.

Authors:  X Wei; G Peng; S Zheng; X Wu
Journal:  Cell Prolif       Date:  2012-02-13       Impact factor: 6.831

2.  Low DHEAS levels are associated with depressive symptoms in elderly Chinese men: results from a large study.

Authors:  Samuel Y S Wong; Jason C Leung; Timothy Kwok; Claes Ohlsson; Liesbeth Vandenput; Ping C Leung; Jean Woo
Journal:  Asian J Androl       Date:  2011-08-29       Impact factor: 3.285

Review 3.  The brain-adipocyte-gut network: Linking obesity and depression subtypes.

Authors:  Carla M Patist; Nicolas J C Stapelberg; Eugene F Du Toit; John P Headrick
Journal:  Cogn Affect Behav Neurosci       Date:  2018-12       Impact factor: 3.282

4.  Testosterone and specific symptoms of depression: Evidence from NHANES 2011-2016.

Authors:  Ilmari Määttänen; Kia Gluschkoff; Kaisla Komulainen; Jaakko Airaksinen; Kateryna Savelieva; Regina García-Velázquez; Markus Jokela
Journal:  Compr Psychoneuroendocrinol       Date:  2021-03-10

Review 5.  Why estrogens matter for behavior and brain health.

Authors:  Liisa A M Galea; Karyn M Frick; Elizabeth Hampson; Farida Sohrabji; Elena Choleris
Journal:  Neurosci Biobehav Rev       Date:  2016-03-31       Impact factor: 8.989

6.  Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

Authors:  Sarah L Kerns; Chunkit Fung; Patrick O Monahan; Shirin Ardeshir-Rouhani-Fard; Mohammad I Abu Zaid; AnnaLynn M Williams; Timothy E Stump; Howard D Sesso; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair Beard; Robert A Huddart; Jeri Kim; Christian Kollmannsberger; Deepak M Sahasrabudhe; Ryan Cook; Sophie D Fossa; Lawrence H Einhorn; Lois B Travis
Journal:  J Clin Oncol       Date:  2018-04-04       Impact factor: 44.544

7.  Depression symptoms associated with cannabis dependence in an adolescent American Indian community sample.

Authors:  David A Gilder; Cindy L Ehlers
Journal:  Am J Addict       Date:  2012-09-27

8.  Testosterone levels in suicide attempters with bipolar disorder.

Authors:  Leo Sher; Michael F Grunebaum; Gregory M Sullivan; Ainsley K Burke; Thomas B Cooper; J John Mann; Maria A Oquendo
Journal:  J Psychiatr Res       Date:  2012-07-31       Impact factor: 4.791

9.  Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Authors:  Prasanth N Surampudi; Christina Wang; Ronald Swerdloff
Journal:  Int J Endocrinol       Date:  2012-03-14       Impact factor: 3.257

10.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.